Literature DB >> 10560724

Sensitivity and specificity of HIV-1 testing of urine compared with serum specimens: Rakai, Uganda. The Rakai Project Team.

M P Meehan1, N K Sewankambo, M J Wawer, D McNairn, T C Quinn, T Lutalo, S Kalibbala, C Li, D Serwadda, F Wabwire-Mangen, R H Gray.   

Abstract

BACKGROUND AND OBJECTIVES: To evaluate a urine HIV-1 test. STUDY
DESIGN: Paired urine and blood samples from a sample of 222 subjects were assayed for HIV-1 using Calypte HIV-1 Urine enzyme immunoassay (EIA) with Western blot (WB) confirmation, and sera were tested by EIA and WB. Masked assays were done on stored, refrigerated urine at Johns Hopkins University (JH), and on fresh specimens at the Rakai Project, Entebbe (RP). We assessed the sensitivity and specificity of the urine relative to serum assays.
RESULTS: Compliance with provision of urine samples (95.0%) was higher than provision of serum (90.5%). Ninety-six sera were HIV-positive; 92 were HIV-positive on stored urine at JH (sensitivity 95.8%, CI 91.8-99.8%); and 94 (100%) were positive on fresh samples at the RP laboratory (sensitivity = 100.0%). Among serum HIV-negative subjects, all frozen urine were negative at JH and 97.7% of fresh samples were negative at RP.
CONCLUSIONS: The Calypte urine HIV-1 EIA with WB is sensitive and specific. In this population, provision of urine was more acceptable than provision of blood samples.

Entities:  

Mesh:

Year:  1999        PMID: 10560724     DOI: 10.1097/00007435-199911000-00009

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  2 in total

1.  Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a brazilian study.

Authors:  Walter M R Oelemann; Catherine M Lowndes; Giovani C Veríssimo Da Costa; Mariza G Morgado; Luiz Roberto R Castello-Branco; Beatriz Grinsztejn; Michel Alary; Francisco I Bastos
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Are healthcare workers at higher risk of HIV infection than the general population in Burkina Faso?

Authors:  F Kirakoya-Samadoulougou; P Fao; S Yaro; M-C Defer; N Meda; A Robert; N Nagot
Journal:  Epidemiol Infect       Date:  2013-06-13       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.